Clinical Trial Update: A Multiple Dose Investigational Drug Study in Patients With Type 2 Diabetes (MK-0941-005) [Phase 1]

View source ↗

Summary

This Phase 1, multiple-dose study of the investigational diabetes drug MK-0941-005 in adults with type 2 diabetes has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-0941

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2012-06-26